Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Endtz

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Infection Control and Hospital Epidemiology|September 1, 2000
Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The NetherlandsN van den Braak, A Ott, A van Belkum, et al.
Journal of Clinical Microbiology|December 17, 1997
Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The NetherlandsH P Endtz, N van den Braak, A van Belkum, et al.
Journal of Clinical Microbiology|June 2, 2000
Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromesH P Endtz, C W Ang, N van Den Braak, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 30, 2009
Effects of local climate variability on transmission dynamics of cholera in Matlab, BangladeshM S Islam, M A Y Sharker, S Rheman, et al.
Global Health Action|December 14, 2017
ZikaPLAN: Zika Preparedness Latin American NetworkA Wilder-Smith, R Preet, K E Renhorn, et al.
Applied and Environmental Microbiology|April 3, 2001
Investigating microbial (micro)colony heterogeneity by vibrational spectroscopyL P Choo-Smith, K Maquelin, T van Vreeswijk, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 5, 2012
A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndromeR Louwen, D Horst-Kreft, A G de Boer, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and AustraliaD M Livermore, M W Carter, S Bagel, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Infection Control and Hospital Epidemiology|September 1, 2000
Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The NetherlandsN van den Braak, A Ott, A van Belkum, et al.
Journal of Clinical Microbiology|December 17, 1997
Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The NetherlandsH P Endtz, N van den Braak, A van Belkum, et al.
Journal of Clinical Microbiology|June 2, 2000
Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromesH P Endtz, C W Ang, N van Den Braak, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 30, 2009
Effects of local climate variability on transmission dynamics of cholera in Matlab, BangladeshM S Islam, M A Y Sharker, S Rheman, et al.
Global Health Action|December 14, 2017
ZikaPLAN: Zika Preparedness Latin American NetworkA Wilder-Smith, R Preet, K E Renhorn, et al.
Applied and Environmental Microbiology|April 3, 2001
Investigating microbial (micro)colony heterogeneity by vibrational spectroscopyL P Choo-Smith, K Maquelin, T van Vreeswijk, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 5, 2012
A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndromeR Louwen, D Horst-Kreft, A G de Boer, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and AustraliaD M Livermore, M W Carter, S Bagel, et al.
Pageof 8